CCCCNC(=O)O[C@@H]1C[C@@H]2CCN3C(=O)CCC[C@@H]([C@H]23)[C@H]1CC
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?